These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8995035)

  • 21. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of new markers of bone metabolism in renal osteodystrophy in children].
    Deschenes G; Souberbielle JC; Brunelle F; Dechaux M
    Ann Pediatr (Paris); 1990 Feb; 37(2):120-2. PubMed ID: 2181914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
    Arora N; Sandroni S; Moles K
    Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The causes of the end of growth hormone treatment in children with chronic renal failure].
    Leszczyńiska B; Ziółkowska H; Majcher A; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():153-5. PubMed ID: 16898517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances of clinical diagnosis of osteodystrophy complicated by chronic renal failure].
    Nowak Z
    Pol Merkur Lekarski; 1998 Nov; 5(29):313-6. PubMed ID: 10101511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of early renal osteodystrophy.
    Eke FU; Winterborn MH; Robertson PW
    Child Nephrol Urol; 1988-1989; 9(1-2):33-7. PubMed ID: 3251619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is renal osteodystrophy reversible?
    Madsen S; Thaysen JH; Olgaard K; Heerfordt J; Løkkegaard H
    Proc Eur Dial Transplant Assoc; 1977; 14():433-41. PubMed ID: 341142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on bone markers and bone mineral density in patients with chronic renal failure.
    Ha SK; Park CH; Seo JK; Park SH; Kang SW; Choi KH; Lee HY; Han DS
    Yonsei Med J; 1996 Oct; 37(5):350-6. PubMed ID: 8997167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group.
    Powell DR; Durham SK; Brewer ED; Frane JW; Watkins SL; Hogg RJ; Mohan S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):596-601. PubMed ID: 10022422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium supplementation increases bone mass in GH-deficient prepubertal children during GH replacement.
    Zamboni G; Antoniazzi F; Lauriola S; Bertoldo F; Tatò L
    Horm Res; 2006; 65(5):223-30. PubMed ID: 16569932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reevaluation of the usefulness of serum free hydroxyproline as a parameter for assessing renal osteodystrophy.
    Uehara H
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):49-58. PubMed ID: 8336400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study on the relative factors for secondary parathyroidosis and renal osteodystrophy in long-term hemodialysis patients].
    Pan J; Zhu L; Huang Z
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):161-4. PubMed ID: 7648935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.